Literature DB >> 22375050

Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.

Angelika Schmidt1, Nina Oberle, Eva-Maria Weiss, Diana Vobis, Stefan Frischbutter, Ria Baumgrass, Christine S Falk, Mathias Haag, Britta Brügger, Hongying Lin, Georg W Mayr, Peter Reichardt, Matthias Gunzer, Elisabeth Suri-Payer, Peter H Krammer.   

Abstract

CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity. T(regs) inhibit the proliferation of CD4(+)CD25(-) conventional T cells (T(cons)), as well as the ability of these cells to produce effector cytokines; however, the molecular mechanism of suppression remains unclear. Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons). The inhibition of Ca(2+) signaling resulted in decreased dephosphorylation, and thus decreased activation, of the transcription factor nuclear factor of activated T cells 1 (NFAT1) and reduced the activation of nuclear factor κB (NF-κB). In contrast, Ca(2+)-independent events in T(cons), such as TCR-proximal signaling and activation of the transcription factor activator protein 1 (AP-1), were not affected during coculture with T(regs). Despite suppressing intracellular Ca(2+) mobilization, coculture with T(regs) did not block the generation of inositol 1,4,5-trisphosphate in TCR-stimulated T(cons). The T(reg)-induced suppression of the activity of NFAT and NF-κB and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+). Our results elucidate a previously unrecognized and rapid mechanism of T(reg)-mediated suppression. This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22375050     DOI: 10.1126/scisignal.2002179

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  31 in total

1.  Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

Authors:  Angelika Schmidt; Francesco Marabita; Narsis A Kiani; Catharina C Gross; Henrik J Johansson; Szabolcs Éliás; Sini Rautio; Matilda Eriksson; Sunjay Jude Fernandes; Gilad Silberberg; Ubaid Ullah; Urvashi Bhatia; Harri Lähdesmäki; Janne Lehtiö; David Gomez-Cabrero; Heinz Wiendl; Riitta Lahesmaa; Jesper Tegnér
Journal:  BMC Biol       Date:  2018-05-07       Impact factor: 7.431

2.  In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.

Authors:  Angelika Schmidt; Szabolcs Éliás; Rubin N Joshi; Jesper Tegnér
Journal:  J Vis Exp       Date:  2016-12-30       Impact factor: 1.355

3.  Seeing is believing: Visualizing immune cells and calcium signals at different stages of neuroinflammation.

Authors:  Liwei Wang; Stefan Feske
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-07       Impact factor: 11.205

4.  Fabrications of boron-containing apatite ceramics via ultrasonic spray-pyrolysis route and their responses to immunocytes.

Authors:  Daiki Nakagawa; Mariko Nakamura; Shigenori Nagai; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

5.  The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity.

Authors:  Rebecca Breuer; Michael S Becker; Markus Brechmann; Thomas Mock; Rüdiger Arnold; Peter H Krammer
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

Review 6.  Regulatory T cells in autoimmune neuroinflammation.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

7.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Authors:  Giuseppe Matarese; Claudia La Rocca; Hyun-Seuk Moon; Joo Young Huh; Mary T Brinkoetter; Sharon Chou; Francesco Perna; Dario Greco; Holly P Kilim; Chuanyun Gao; Kalliope Arampatzi; Zhaoxi Wang; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 9.  Induced and natural regulatory T cells in human cancer.

Authors:  Theresa L Whiteside; Patrick Schuler; Bastian Schilling
Journal:  Expert Opin Biol Ther       Date:  2012-07-31       Impact factor: 4.388

10.  Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.

Authors:  Sadna Budhu; David A Schaer; Yongbiao Li; Ricardo Toledo-Crow; Katherine Panageas; Xia Yang; Hong Zhong; Alan N Houghton; Samuel C Silverstein; Taha Merghoub; Jedd D Wolchok
Journal:  Sci Signal       Date:  2017-08-29       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.